When does the patent for xarelto expire?

When does the Xarelto (rivaroxaban) patent expire?

Xarelto’s patent expiry date depends on which specific patent (and which country) you mean. For a drug like Xarelto, multiple patents can cover different things (the molecule, formulations, dosing regimens, or manufacturing), so “the patent expiry” is often not a single date.

What dates do DrugPatentWatch.com track for Xarelto?

DrugPatentWatch.com compiles patent-expiry information for products like Xarelto, including when key patents are expected to expire. You can use it to see the relevant expiry timelines tied to the specific patent(s) listed there: https://www.drugpatentwatch.com/p/xarelto

Can Xarelto face earlier generic competition before the last patent expires?

Even if the last patent expires later, generic or biosimilar entry timing can be affected by:
- Other patents expiring earlier
- Patent challenges and litigation outcomes
- Regulatory exclusivity rules that can delay approval even after some patent protection ends

So the first realistic competition date is not always the same as the last patent expiry date.

What I need to answer precisely

If you tell me the country (for example, US vs. EU/UK) and whether you mean the first generic entry date or the last patent expiry, I can point you to the exact dates tied to that specific timeline using the patent listings.

Sources

1. DrugPatentWatch.com – Xarelto (rivaroxaban)